Lauren Massaro

In case you missed it, this week we had news about student-athlete suicides, the benefits of omega-3, the rise in tianeptine across the US, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Semaglutide reduced the risk of major kidney disease and cardiovascular (CV) events, and death from any cause, while simultaneously decelerating the loss of kidney function, among patients with type 2 diabetes (T2D) and CKD compared to placebo.

Participants with the hungry gut phenotype, identified by the MyPhenome Hungry Gut test, were able to lose double the amount of weight on semaglutide compared to those without.

Study findings can raise awareness for both patients and health care providers about vitamin D deficiency as a potential contributor to bleeding risk, as well as lead to more personalized treatment approaches for patients on blood thinners.

Research presented at Digestive Disease Week suggests that including omega-3 rich foods, or omega-3 supplements, into a healthy diet could offer additional protection against colorectal cancer alongside regular screening.

Health care providers must listen to patients who voice their experiences with post–COVID-19 condition symptoms. Only then can a clearer picture of the condition emerge for the millions of patients who have the near-invisible disease.

In case you missed it, this week we had news about joint business ventures in pharmacy, an uptick in fentanyl seizures across the US, sunscreen safety, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.”

Pharmacists must take a multifaceted approach to educating patients on sun safety that extends beyond sunscreen counseling, according to Colleen McCabe, PharmD, BCOP.

Colleen McCabe, PharmD, BCOP, emphasizes the importance of a proactive and tailored approach for pharmacists educating patients on skin cancer risks specific to their communities.

Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.

Dynavax plans to meet with the FDA to discuss how the company can provide additional data to support the approval of its 4-dose Heplisav-B regimen and expand protection for adults with end-stage renal disease (ESRD) on hemodialysis.

For Melanoma and Skin Cancer Awareness Month, Drug Topics sat down with Colleen McCabe, PharmD, BCOP, to glean clinical insights into promoting skin cancer awareness in the community pharmacy.

Study results suggest a nationwide increase in the supply and availability of illicitly manufactured fentanyl, with pills becoming more dominant across the ever-shifting US fentanyl market.

In case you missed it, this week we had news about pharmacy issues in the election spotlight, advancements in psychedelic therapeutics, prior authorization, and more.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.

Tandem Diabetes Care, Inc has reported 224 injuries associated with a software malfunction in a companion insulin app, leading the company to issue a recall of the technology.

Designs of existing wearables overlook the specific needs of vulnerable populations, hindering their widespread adoption among increasingly interested communities.

Spring and summer not only bring sunshine, but also stronger UV rays. Whether you are barbecuing, swimming, or taking a hike, skin protection is paramount while soaking up the sunshine.

See what's trending in pharmacy with a preview of the Drug Topics May issue.

Recent research exploring the gut-skin connection shows that dietary modifications and probiotic supplements may help skin conditions like acne, atopic dermatitis, and rosacea.

In case you missed it, this week we had news about marijuana reclassification, the Change Healthcare cyberattack, declining wages among community pharmacists, and more.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.

Are you a Wookie with a mane to maintain or a scoundrel prone to nausea? You don’t have to traverse distant planets to find OTC recommendations that meet your needs—this guide has you covered.

The current study highlights the potential benefit of incorporating continuous glucose monitor (CGM) data into eye care assessments for patients with type 1 diabetes (T1D).

According to Michael Osso, president and chief executive officer of the Crohn’s & Colitis Foundation, “the flexibility of having multiple biosimilar formulations to choose from is important to support broader patient access to biologic medicine.”

Although the US Drug Enforcement Agency's (DEA) proposed reclassification of marijuana wouldn’t legalize the drug nationwide, it could shake up the current marijuana landscape.

Pemivibart will act as an additional preventive option for COVID-19 among moderately-to-severely immunocompromised adult and adolescent patients, who are disproportionally impacted by the condition.